img Leseprobe Sample

Ralph Edwards: RARE EVENTS

The Inside Story of a Worldwide Quest for Safer Medicines

Ian Hembrow

PDF
ca. 85,59
Amazon iTunes Thalia.de Weltbild.de Hugendubel Bücher.de ebook.de kobo Osiander Google Books Barnes&Noble bol.com Legimi yourbook.shop Kulturkaufhaus ebooks-center.de
* Affiliate Links
Hint: Affiliate Links
Links on findyourbook.com are so-called affiliate links. If you click on such an affiliate link and buy via this link, findyourbook.com receives a commission from the respective online shop or provider. For you, the price doesn't change.

Springer International Publishing img Link Publisher

Naturwissenschaften, Medizin, Informatik, Technik / Pharmazie

Description

Medical treatments designed to help people can also be harmful or fatal. Around 2.5 million people die this way each year. So if any kind of medicine makes someone unwell, they or their doctor should report it. Those reports, from nearly every country in the world, go to the Uppsala Monitoring Centre (UMC) in Sweden. 

As the Centre’s first director, Professor Ivor Ralph Edwards transformed it from a tiny operation with limited horizons into an internationally acclaimed scientific organization at the heart of the World Health Organization’s Programme for International Drug Monitoring. He was then succeeded by his wife, Dr Marie Lindquist.

This is the story of how a new science developed and a passionate and dedicated pursuit of worldwide medicines safety, with an unerring focus on the welfare of patients. The pioneering work of Ralph, Marie and their collaborators on every continent protected the lives of millions of people. It may yet improve the lives of billions more. 

More E-books By This Author
Ian Hembrow
More E-books At The Same Price
Cover Drug Delivery and Targeting
Monika Schäfer-Korting
Cover Pharmacist Humor
Irene Xanderena
Cover Quality Assurance
Bhupinder Kumar

customer reviews

Keywords

World Health Organization, Uppsala Monitoring Centre, Medicines safety, WHO Drug Dictionary, Rare side effects, Dispositionality, Drug monitoring, Adverse reactions/events, Epidemiology, Global pharmacovigilance